Free Trial

Motus GI Q4 2022 Earnings Report

Motus GI logo
$0.0001 0.00 (-50.00%)
(As of 12/20/2024 03:04 PM ET)

Motus GI EPS Results

Actual EPS
-$11.85
Consensus EPS
-$18.75
Beat/Miss
Beat by +$6.90
One Year Ago EPS
N/A

Motus GI Revenue Results

Actual Revenue
$0.11 million
Expected Revenue
$0.40 million
Beat/Miss
Missed by -$290.00 thousand
YoY Revenue Growth
N/A

Motus GI Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

Motus GI Earnings Headlines

Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
See More Motus GI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Motus GI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Motus GI and other key companies, straight to your email.

About Motus GI

Motus GI (NASDAQ:MOTS) operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

View Motus GI Profile

More Earnings Resources from MarketBeat

Upcoming Earnings